Stephen Inglis


Stephen joined the National Institute for Biological Standards and Control (NIBSC) after 10 years’ experience in the biotechnology industry, latterly as Research Director of Cantab Pharmaceuticals. From 1980 to 1990 he was a lecturer in the Department of Pathology at Cambridge University specialising in research on the molecular biology of RNA viruses.

Previous roles in government

  • Interim Chief Scientific Officer